Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S
Sprint Corporation
S
|
+$664M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$612M |
| 3 |
Pfizer
PFE
|
+$224M |
| 4 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$160M |
| 5 |
JPMorgan Chase
JPM
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$631M |
| 2 |
FON
SPRINT CORP FON COM
FON
|
+$365M |
| 3 |
Zoetis
ZTS
|
+$275M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
Ameriprise Financial
AMP
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.46% |
| 2 | Technology | 13.23% |
| 3 | Healthcare | 11.93% |
| 4 | Energy | 10.39% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cardinal Health
CAH
$53.9B
| $148M | 0.09% |
2,844,862
+78,257
| +3% | +$3.98M |
|
|
VMRK
227
Vivmark Residential
VMRK
$50.8B
| $148M | 0.09% |
2,762,135
-3,358
| -0.1% | -$185K |
|
228
Flowserve
FLS
$9.02B
| $147M | 0.09% |
2,356,221
-4,026
| -0.2% | -$233K |
|
229
Healthpeak Properties
DOC
$14B
| $147M | 0.09% |
3,934,383
| – | – |
|
|
PARA
230
DELISTED
Paramount Global Class B
PARA
| $145M | 0.08% |
2,629,845
-292,773
| -10% | -$15.6M |
|
231
Vertex Pharmaceuticals
VRTX
$131B
| $144M | 0.08% |
1,904,743
+1,037,398
| +120% | +$82.6M |
|
|
LNKD
232
DELISTED
LinkedIn Corporation
LNKD
| $143M | 0.08% |
581,347
+150,606
| +35% | +$33.9M |
|
|
AGN
233
DELISTED
Allergan plc
AGN
| $142M | 0.08% |
985,148
+481,582
| +96% | +$64.2M |
|
234
Gen Digital
GEN
$18.7B
| $142M | 0.08% |
5,722,583
| – | – |
|
235
Sherwin-Williams
SHW
$78.6B
| $141M | 0.08% |
2,326,524
-87,837
| -4% | -$5.16M |
|
236
Norfolk Southern
NSC
$72.2B
| $141M | 0.08% |
1,819,653
-237,876
| -12% | -$17.8M |
|
237
Ventas
VTR
$45.4B
| $141M | 0.08% |
2,001,806
-71,363
| -3% | -$5.29M |
|
238
Aptiv
APTV
$9.13B
| $141M | 0.08% |
2,405,275
+1,032,406
| +75% | +$57.4M |
|
|
BHI
239
DELISTED
Baker Hughes
BHI
| $139M | 0.08% |
2,836,395
-420,736
| -13% | -$20.3M |
|
240
Motorola Solutions
MSI
$77.4B
| $139M | 0.08% |
2,342,334
-49,949
| -2% | -$2.87M |
|
|
MRSH
241
Marsh
MRSH
$85.8B
| $139M | 0.08% |
3,190,264
-993,872
| -24% | -$41.8M |
|
242
Welltower
WELL
$168B
| $138M | 0.08% |
2,213,955
+169,773
| +8% | +$10.8M |
|
243
OGE Energy
OGE
$9.46B
| $138M | 0.08% |
3,814,627
-198,093
| -5% | -$7.16M |
|
|
STJ
244
DELISTED
St Jude Medical
STJ
| $137M | 0.08% |
2,562,595
-37,872
| -1% | -$1.95M |
|
245
Fomento Económico Mexicano
FMX
$41.4B
| $137M | 0.08% |
1,411,676
| – | – |
|
246
Agilent Technologies
A
$42.3B
| $137M | 0.08% |
3,734,807
-268,197
| -7% | -$9.04M |
|
247
Imperial Oil
IMO
$65.8B
| $135M | 0.08% |
3,067,090
+145,422
| +5% | +$6.1M |
|
|
TYC
248
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $134M | 0.08% |
3,665,086
+516,178
| +16% | +$18.7M |
|
249
PG&E
PCG
$29B
| $134M | 0.08% |
3,273,900
-1,306,637
| -29% | -$56.8M |
|
250
T. Rowe Price
TROW
$22.4B
| $134M | 0.08% |
1,858,281
-82,806
| -4% | -$6.13M |
|
Similar funds
Norges Bank's Q3 2013 Portfolio in Review
As of Q3 2013, Norges Bank held 2,123 positions worth $171B, up 6.4% from $161B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2013: portfolio turnover was 2.6%. Norges Bank opened 16 new positions and exited 39, leaving the 2,123-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
- Norges Bank's largest Q3 2013 buy was Sprint Corporation: 100,920,567 shares worth $627M.
- Norges Bank added most to Pfizer in Q3 2013, an estimated $224M increase.
- Norges Bank's biggest Q3 2013 reduction was Zoetis, cutting an estimated $275M.
- Norges Bank fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $631M.
- Norges Bank's ten largest holdings make up 14% of its $171B portfolio in Q3 2013.
- Norges Bank opened 16 new positions and closed 39 in Q3 2013.
- Norges Bank's portfolio value rose 6.4% quarter-over-quarter to $171B.
Based on Norges Bank's 13F filing for Q3 2013, filed 12 Nov 2013.